Provided by Tiger Trade Technology Pte. Ltd.

Adial Pharmaceuticals

5.82
+0.42007.78%
Pre-market: 5.36-0.4600-7.90%05:03 EDT
Volume:32.14K
Turnover:182.40K
Market Cap:15.28M
PE:-0.33
High:5.90
Open:5.35
Low:5.19
Close:5.40
52wk High:10.75
52wk Low:1.31
Shares:2.63M
Float Shares:1.82M
Volume Ratio:0.34
T/O Rate:1.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-17.7100
EPS(LYR):-11.9306
ROE:-2011.64%
ROA:-40.02%
PB:-0.40
PE(LYR):-0.49

Loading ...

Adial Pharma Grants Unregistered Option for 307,814 Shares at $5.76 Per Share

Reuters
·
26 mins ago

Adial Pharmaceuticals Grants Inducement Stock Options to New Hire

TIPRANKS
·
12 hours ago

Adial Pharmaceuticals Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
13 hours ago

Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
13 hours ago

Adial Pharmaceuticals Announces Annual Shareholder Meeting

Reuters
·
Yesterday

Adial Pharmaceuticals Faces Nasdaq Listing Compliance Challenge

TIPRANKS
·
Aug 22

Adial Pharmaceuticals Gets NASDAQ Notice for Falling Below $2.5 Million Stockholders’ Equity Minimum

Reuters
·
Aug 22

U.S. Stocks on the MOVE - Sunrun, JetBlue Airways, Dell Technologies

Reuters
·
Aug 17

U.S. Stocks on the MOVE - KBR, Vista Energy, Fulcrum Therapeutics

Reuters
·
Aug 17

Adial Pharmaceuticals Q2 EPS $(11.25)

Benzinga Earnings
·
Aug 17

Adial Pharmaceuticals Falls After Quarterly Loss Widens

Reuters
·
Aug 17

Adial Pharmaceuticals Posts Bigger-than-Expected Q2 Net Loss, Hurt by Acquisition Charges

Reuters
·
Aug 17

Adial Pharmaceuticals Q2 Net Income USD -52 Million

THOMSON REUTERS
·
Aug 17

Press Release: Adial Pharmaceuticals Reports 2026 Second Quarter Financial Results and Provides Business Update

Dow Jones
·
Aug 17

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 17

Adial Pharma Faces Governance Risks and Major Dilution as 2026 Shareholder Vote Looms on Preferred Conversions and Warrants

TIPRANKS
·
Aug 16

Adial Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 15

Adial Q2 Net Loss Widens to $51.99 Million from Year-Ago Quarter

Reuters
·
Aug 15

Adial Pharmaceuticals Plans Major Leadership and Board Transition

TIPRANKS
·
Aug 14

Adial Pharmaceuticals - as of Aug 10, Anticipates Termination of CEO Cary Claiborne After 2026 Annual Meeting

Reuters
·
Aug 14